Linzess sanctioned for cases that don’t respond to conventional treatment THURSDAY, Aug. 30 (HealthDay News) — Linzess (linaclotide) has been approved by the U.S. Food and Drug Administration to treat forms of chronic constipation that don’t respond to traditional treatment, and irritable bowel syndrome accompanied by constipation, the agency said Thursday in a news release....

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

Study runs counter to previous research that suggested caloric restriction might boost longevity By Carina StorrsHealthDay Reporter WEDNESDAY, Aug. 29 (HealthDay News) — Cutting calories can lead to a number of health benefits, from better metabolism to reduced diabetes and cancer rates, and stronger immune function, according to a new study in monkeys. The long-term...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]

60-minute workout no better for weight loss than half-hour regimen WEDNESDAY, Aug. 29 (HealthDay News) — Thirty minutes of daily exercise achieves the same amount of weight loss as 60 minutes, according to a small new study. The research included 60 heavy but healthy Danish men who exercised for either 30 or 60 minutes a...

[[ This is a content summary only. Visit my website for full links, other content, and more! ]]